
Dengue Vaccine Global Market Report 2025
Description
Dengue Vaccine Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on dengue vaccine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Where is the largest and fastest growing market for dengue vaccine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The dengue vaccine market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered:1) By Type: Live Attenuated Vaccine; Chimeric Live Attenuated Vaccine; Inactivated Vaccine; Subunit Vaccine; Nucleic Acid Based Vaccine
2) By Vaccine Phase: Phase I; Phase II; Phase III
3) By Treatment: Diuretic; Anti-Allergic; Blood Thinners; Other Treatments
4) By Route Of Administration: Oral; Parenteral; Other Routes Of Administration
5) By End-User: Hospitals; Clinics; Government Institutes; Non-Governmental Organizations; Other End-Users
Subsegments:
1) By Live Attenuated Vaccine: Single Strain; Multi-Strain
2) By Chimeric Live Attenuated Vaccine: Tetravalent Chimeric Vaccine; Monovalent Chimeric Vaccine
3) By Inactivated Vaccine: Whole Virus Inactivated Vaccine; Split Virus Vaccine
4) By Subunit Vaccine: Recombinant Protein Vaccine; Peptide-Based Vaccine
5) By Nucleic Acid Based Vaccine: DNA Vaccine; mRNA Vaccine
Companies Mentioned: Merck & Co. Inc.; Sanofi Pasteur Limited; GlaxoSmithKline plc; Takeda Pharmaceutical Company; Sun Pharmaceutical Industries Ltd.; Biological E. Limited; Saint Louis University; Indian Immunologicals Limited; Serum Institute of India Pvt. Ltd.; Bavarian Nordic; Instituto Butantan; Bharat Biotech Ltd.; Panacea Biotec Limited; SABIN Vaccine Institute; Medigen Vaccine Biologics Corporation; Emergex Vaccines Holding Ltd.; BioNet-Asia Co. Ltd.; Codagenix Inc.; KM Biologics Co. Ltd.; Chula Vaccine Research Center; Imutex Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
This report focuses on dengue vaccine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for dengue vaccine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The dengue vaccine market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Type: Live Attenuated Vaccine; Chimeric Live Attenuated Vaccine; Inactivated Vaccine; Subunit Vaccine; Nucleic Acid Based Vaccine
2) By Vaccine Phase: Phase I; Phase II; Phase III
3) By Treatment: Diuretic; Anti-Allergic; Blood Thinners; Other Treatments
4) By Route Of Administration: Oral; Parenteral; Other Routes Of Administration
5) By End-User: Hospitals; Clinics; Government Institutes; Non-Governmental Organizations; Other End-Users
Subsegments:
1) By Live Attenuated Vaccine: Single Strain; Multi-Strain
2) By Chimeric Live Attenuated Vaccine: Tetravalent Chimeric Vaccine; Monovalent Chimeric Vaccine
3) By Inactivated Vaccine: Whole Virus Inactivated Vaccine; Split Virus Vaccine
4) By Subunit Vaccine: Recombinant Protein Vaccine; Peptide-Based Vaccine
5) By Nucleic Acid Based Vaccine: DNA Vaccine; mRNA Vaccine
Companies Mentioned: Merck & Co. Inc.; Sanofi Pasteur Limited; GlaxoSmithKline plc; Takeda Pharmaceutical Company; Sun Pharmaceutical Industries Ltd.; Biological E. Limited; Saint Louis University; Indian Immunologicals Limited; Serum Institute of India Pvt. Ltd.; Bavarian Nordic; Instituto Butantan; Bharat Biotech Ltd.; Panacea Biotec Limited; SABIN Vaccine Institute; Medigen Vaccine Biologics Corporation; Emergex Vaccines Holding Ltd.; BioNet-Asia Co. Ltd.; Codagenix Inc.; KM Biologics Co. Ltd.; Chula Vaccine Research Center; Imutex Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents
175 Pages
- 1. Executive Summary
- 2. Dengue Vaccine Market Characteristics
- 3. Dengue Vaccine Market Trends And Strategies
- 4. Dengue Vaccine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
- 4.1. Supply Chain Impact from Tariff War & Trade Protectionism
- 5. Global Dengue Vaccine Growth Analysis And Strategic Analysis Framework
- 5.1. Global Dengue Vaccine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Dengue Vaccine Market Growth Rate Analysis
- 5.4. Global Dengue Vaccine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Dengue Vaccine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Dengue Vaccine Total Addressable Market (TAM)
- 6. Dengue Vaccine Market Segmentation
- 6.1. Global Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Live Attenuated Vaccine
- Chimeric Live Attenuated Vaccine
- Inactivated Vaccine
- Subunit Vaccine
- Nucleic Acid Based Vaccine
- 6.2. Global Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Phase I
- Phase II
- Phase III
- 6.3. Global Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Diuretic
- Anti-Allergic
- Blood Thinners
- Other Treatments
- 6.4. Global Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oral
- Parenteral
- Other Routes Of Administration
- 6.5. Global Dengue Vaccine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Clinics
- Government Institutes
- Non-Governmental Organizations
- Other End-Users
- 6.6. Global Dengue Vaccine Market, Sub-Segmentation Of Live Attenuated Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Single Strain
- Multi-Strain
- 6.7. Global Dengue Vaccine Market, Sub-Segmentation Of Chimeric Live Attenuated Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Tetravalent Chimeric Vaccine
- Monovalent Chimeric Vaccine
- 6.8. Global Dengue Vaccine Market, Sub-Segmentation Of Inactivated Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Whole Virus Inactivated Vaccine
- Split Virus Vaccine
- 6.9. Global Dengue Vaccine Market, Sub-Segmentation Of Subunit Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Recombinant Protein Vaccine
- Peptide-Based Vaccine
- 6.10. Global Dengue Vaccine Market, Sub-Segmentation Of Nucleic Acid Based Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- DNA Vaccine
- mRNA Vaccine
- 7. Dengue Vaccine Market Regional And Country Analysis
- 7.1. Global Dengue Vaccine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Dengue Vaccine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific Dengue Vaccine Market
- 8.1. Asia-Pacific Dengue Vaccine Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China Dengue Vaccine Market
- 9.1. China Dengue Vaccine Market Overview
- 9.2. China Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India Dengue Vaccine Market
- 10.1. India Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan Dengue Vaccine Market
- 11.1. Japan Dengue Vaccine Market Overview
- 11.2. Japan Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia Dengue Vaccine Market
- 12.1. Australia Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia Dengue Vaccine Market
- 13.1. Indonesia Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea Dengue Vaccine Market
- 14.1. South Korea Dengue Vaccine Market Overview
- 14.2. South Korea Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe Dengue Vaccine Market
- 15.1. Western Europe Dengue Vaccine Market Overview
- 15.2. Western Europe Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK Dengue Vaccine Market
- 16.1. UK Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany Dengue Vaccine Market
- 17.1. Germany Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France Dengue Vaccine Market
- 18.1. France Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy Dengue Vaccine Market
- 19.1. Italy Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain Dengue Vaccine Market
- 20.1. Spain Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe Dengue Vaccine Market
- 21.1. Eastern Europe Dengue Vaccine Market Overview
- 21.2. Eastern Europe Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia Dengue Vaccine Market
- 22.1. Russia Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America Dengue Vaccine Market
- 23.1. North America Dengue Vaccine Market Overview
- 23.2. North America Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA Dengue Vaccine Market
- 24.1. USA Dengue Vaccine Market Overview
- 24.2. USA Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada Dengue Vaccine Market
- 25.1. Canada Dengue Vaccine Market Overview
- 25.2. Canada Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America Dengue Vaccine Market
- 26.1. South America Dengue Vaccine Market Overview
- 26.2. South America Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil Dengue Vaccine Market
- 27.1. Brazil Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East Dengue Vaccine Market
- 28.1. Middle East Dengue Vaccine Market Overview
- 28.2. Middle East Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa Dengue Vaccine Market
- 29.1. Africa Dengue Vaccine Market Overview
- 29.2. Africa Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. Dengue Vaccine Market Competitive Landscape And Company Profiles
- 30.1. Dengue Vaccine Market Competitive Landscape
- 30.2. Dengue Vaccine Market Company Profiles
- 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Sanofi Pasteur Limited Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Takeda Pharmaceutical Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Sun Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 31. Dengue Vaccine Market Other Major And Innovative Companies
- 31.1. Biological E. Limited
- 31.2. Saint Louis University
- 31.3. Indian Immunologicals Limited
- 31.4. Serum Institute of India Pvt. Ltd.
- 31.5. Bavarian Nordic
- 31.6. Instituto Butantan
- 31.7. Bharat Biotech Ltd.
- 31.8. Panacea Biotec Limited
- 31.9. SABIN Vaccine Institute
- 31.10. Medigen Vaccine Biologics Corporation
- 31.11. Emergex Vaccines Holding Ltd.
- 31.12. BioNet-Asia Co. Ltd.
- 31.13. Codagenix Inc.
- 31.14. KM Biologics Co. Ltd.
- 31.15. Chula Vaccine Research Center
- 32. Global Dengue Vaccine Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The Dengue Vaccine Market
- 34. Recent Developments In The Dengue Vaccine Market
- 35. Dengue Vaccine Market High Potential Countries, Segments and Strategies
- 35.1 Dengue Vaccine Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Dengue Vaccine Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Dengue Vaccine Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.